Article

Laser vision correction plus RLE may be useful in hyperopia with astigmatism

Washington, DC &#8212 Laser vision correction and refractive lens exchange (RLE) with a multifocal IOL may offer hope for hyperopic eyes with large amounts of astigmatism or residual astigmatism or eyes with presbyopia, according to Kevin L. Waltz, MD, who spoke about the results of retrospective chart review during a cataract/refractive symposium during the American Society of Cataract and Refractive Surgery annual meeting.

April 18 - Washington, DC - Laser vision correction and refractive lens exchange (RLE) with a multifocal IOL may offer hope for hyperopic eyes with large amounts of astigmatism or residual astigmatism or eyes with presbyopia, according to Kevin L. Waltz, MD, who spoke about the results of retrospective chart review during a cataract/refractive symposium during the American Society of Cataract and Refractive Surgery annual meeting.

He reported on a retrospective chart review of 59 eyes of 34 patients who underwent either a planned bioptics procedure or a salvaged bioptics procedure. Some eyes were treated with LASIK before RLE because of extreme cylinder. PRK was performed after RLE in cases of residual astigmatism. LASIK was done after RLE to correct residual astigmatism and defocus.

In addition, RLE was an option after LASIK for defocus and presbyopia, Dr. Waltz said.

Most of the patients had hyperopia, although occasionally patients with extreme myopia were treated.

"The mean sphere was 3.74 D with a fairly wide standard deviation and a fair amount of cylinder," Dr. Waltz noted.

All patients were in the age range beyond the onset of presbyopia. All received the ARRAY multifocal IOL and most laser vision correction was performed with the VISX laser, he said.

Postoperatively, uncorrected visual acuity was good and uncorrected near vision was even better than best-corrected vision preoperatively.

"We find this pretty consistent of all our bioptic procedures and most of the refractive lens procedures for hyperopia," Dr. Waltz said.

However, longer-term follow-up is needed to determine the safety of bioptics.

To date, there have been no adverse complications at 2 years follow-up, he noted.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.